EUVIMEDEUVIMED entdecken
Crossref

Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses

Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, Maryam Hafizi, Hamidreza Jamaati, Seyed Mehdi Hassanzadeh, Akbar Khorasani iD, Mehdi Mahdavi iD, Mohammad Hassan Nazaran iD

Viral Immunology · 2023

DOI: 10.1089/vim.2023.0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, 2023. Verfasst von Somayeh Kalanaky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. Hauptthemen laut MEDLINE: Cytokines, COVID-19. Die Arbeit nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesCOVID-19AnimalsMiceHumansSARS-CoV-2Vaccines, InactivatedCOVID-19 VaccinesAdjuvants, ImmunologicImmunoglobulin GAntibodies, ViralMice, Inbred BALB CAlum Compounds

Stichwörter der Autor:innen

SARS-CoV-2 vaccinenanoadjuvantsnanochelating technologyvaccine formulationsvaccine potency

Substanzen

CytokinesVaccines, InactivatedCOVID-19 VaccinesAdjuvants, ImmunologicImmunoglobulin GAntibodies, Viralaluminum sulfateAlum Compounds

Autor:innen und Institutionen

  • Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of BCG Vaccine Production, Production and Research Complex, Pasteur Institute of Iran, Karaj, Iran.
  • Department of FMD Vaccine Production, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.
  • Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.
  • Recombinant Vaccine Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Akbar Khorasani, Mehdi Mahdavi, Mohammad Hassan Nazaran

Zitieren

APA

Kalanaky, S., Fakharzadeh, S., Karimi, P., Hafizi, M., Jamaati, H., Hassanzadeh, S. M., Khorasani, A., Mahdavi, M., & Nazaran, M. H. (2023). Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Viral Immunology. https://doi.org/10.1089/vim.2023.0001

Vancouver

Kalanaky S, Fakharzadeh S, Karimi P, Hafizi M, Jamaati H, Hassanzadeh SM, et al. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Viral Immunology. 2023. doi:10.1089/vim.2023.0001

BibTeX
@article{Kalanaky2023,
  author = {Kalanaky, Somayeh and Fakharzadeh, Saideh and Karimi, Pegah and Hafizi, Maryam and Jamaati, Hamidreza and Hassanzadeh, Seyed Mehdi and Khorasani, Akbar and Mahdavi, Mehdi and Nazaran, Mohammad Hassan},
  title = {Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses},
  journal = {Viral Immunology},
  year = {2023},
  doi = {10.1089/vim.2023.0001}
}
Kostenlos starten →